Beyond Meat misses quarterly sales and profit estimates

Beyond Meat, Inc. reported fourth-quarter financial results that fell short of Wall Street expectations on Tuesday, as the company continues to struggle with declining demand for its plant-based meat products. The firm posted a revenue decline of 19.7%, bringing quarterly sales to $61.6 million, which trailed the average analyst estimate of $62.6 million. The company's financial health remains under pressure, with an adjusted EBITDA loss of $69 million for the period ending December 31. This figure was significantly wider than the $19.8 million loss anticipated by analysts and the $26 million loss recorded during the same period a year earlier. The disappointing performance led to a nearly 8% drop in share price during extended trading, a sharp contrast to the meme-stock enthusiasm the company experienced in previous years. In the United States, budget-conscious consumers have increasingly shifted toward cheaper, fresh animal-based proteins, moving away from higher-priced processed alternatives. This shift in consumer behavior has created significant hurdles for the plant-based category as a whole. > Results reflect ongoing headwinds in the plant-based meat category as well as the financial impact of several restructuring charges, CEO Ethan Brown said. Operational challenges have further complicated the company's recovery. Beyond Meat disclosed that it is currently unable to estimate when its annual report will be filed. This delay follows the identification of material weaknesses in internal controls related to inventory accounting, specifically concerning excess or obsolete stock. This marks the latest in a series of reporting delays for the firm, which also postponed its third-quarter report last year to assess asset impairment charges. Looking ahead, the company provided a cautious outlook for the first quarter, projecting net revenue between $57 million and $59 million. This guidance sits well below the $66.8 million previously expected by market analysts. While the company saw explosive growth following its 2019 public debut, it has since withdrawn its annual sales targets as it navigates a cooling market and mounting operational costs.